A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

Yi Heng Li; Jaw Wen Chen; Tsung Hsien Lin; Yu Chen Wang; Chau Chung Wu; Hung I. Yeh; Chin Chou Huang; Kuan Cheng Chang; Cho Kai Wu; Po Wei Chen; Chen Wei Huang; Zhih Cherng Chen; Wei Ting Chang; Wei Chun Huang; Chih Yuan Wang; Mei Yueh Lee; A. Ching Chao; Wei Ren Fu; Li Kai Tsai; Sung Chun Tang; Hsin Lung Chan; Yi Ching Yang; Yen Wen Wu; Juey Jen Hwang; Jiunn Lee Lin

doi:10.1016/j.jfma.2019.04.007

A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

Yi Heng Li, Jaw Wen Chen, Tsung Hsien Lin, Yu Chen Wang, Chau Chung Wu, Hung I. Yeh, Chin Chou Huang, Kuan Cheng Chang, Cho Kai Wu, Po Wei Chen, Chen Wei Huang, Zhih Cherng Chen, Wei Ting Chang, Wei Chun Huang, Chih Yuan Wang, Mei Yueh Lee, A. Ching Chao, Wei Ren Fu, Li Kai Tsai, Sung Chun TangHsin Lung Chan, Yi Ching Yang, Yen Wen Wu, Juey Jen Hwang, Jiunn Lee Lin

Research output: Contribution to journal › Review article › peer-review

11 Citations (Scopus)

Abstract

Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.

Original language	English
Pages (from-to)	674-684
Number of pages	11
Journal	Journal of the Formosan Medical Association
Volume	119
Issue number	3
DOIs	https://doi.org/10.1016/j.jfma.2019.04.007
Publication status	Published - 2020 Mar

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1016/j.jfma.2019.04.007

Cite this

Li, Y. H., Chen, J. W., Lin, T. H., Wang, Y. C., Wu, C. C., Yeh, H. I., Huang, C. C., Chang, K. C., Wu, C. K., Chen, P. W., Huang, C. W., Chen, Z. C., Chang, W. T., Huang, W. C., Wang, C. Y., Lee, M. Y., Chao, A. C., Fu, W. R., Tsai, L. K., ... Lin, J. L. (2020). A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan. Journal of the Formosan Medical Association, 119(3), 674-684. https://doi.org/10.1016/j.jfma.2019.04.007

@article{eae582b590ba43abad15898f3f309857,

title = "A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan",

abstract = "Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.",

author = "Li, {Yi Heng} and Chen, {Jaw Wen} and Lin, {Tsung Hsien} and Wang, {Yu Chen} and Wu, {Chau Chung} and Yeh, {Hung I.} and Huang, {Chin Chou} and Chang, {Kuan Cheng} and Wu, {Cho Kai} and Chen, {Po Wei} and Huang, {Chen Wei} and Chen, {Zhih Cherng} and Chang, {Wei Ting} and Huang, {Wei Chun} and Wang, {Chih Yuan} and Lee, {Mei Yueh} and Chao, {A. Ching} and Fu, {Wei Ren} and Tsai, {Li Kai} and Tang, {Sung Chun} and Chan, {Hsin Lung} and Yang, {Yi Ching} and Wu, {Yen Wen} and Hwang, {Juey Jen} and Lin, {Jiunn Lee}",

note = "Publisher Copyright: {\textcopyright} 2019",

year = "2020",

month = mar,

doi = "10.1016/j.jfma.2019.04.007",

language = "English",

volume = "119",

pages = "674--684",

journal = "Journal of the Formosan Medical Association",

issn = "0929-6646",

publisher = "Excerpta Medica Asia Ltd.",

number = "3",

}

Li, YH, Chen, JW, Lin, TH, Wang, YC, Wu, CC, Yeh, HI, Huang, CC, Chang, KC, Wu, CK, Chen, PW , Huang, CW, Chen, ZC, Chang, WT, Huang, WC, Wang, CY, Lee, MY, Chao, AC, Fu, WR, Tsai, LK, Tang, SC, Chan, HL, Yang, YC, Wu, YW, Hwang, JJ & Lin, JL 2020, 'A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan', Journal of the Formosan Medical Association, vol. 119, no. 3, pp. 674-684. https://doi.org/10.1016/j.jfma.2019.04.007

TY - JOUR

T1 - A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

AU - Li, Yi Heng

AU - Chen, Jaw Wen

AU - Lin, Tsung Hsien

AU - Wang, Yu Chen

AU - Wu, Chau Chung

AU - Yeh, Hung I.

AU - Huang, Chin Chou

AU - Chang, Kuan Cheng

AU - Wu, Cho Kai

AU - Chen, Po Wei

AU - Huang, Chen Wei

AU - Chen, Zhih Cherng

AU - Chang, Wei Ting

AU - Huang, Wei Chun

AU - Wang, Chih Yuan

AU - Lee, Mei Yueh

AU - Chao, A. Ching

AU - Fu, Wei Ren

AU - Tsai, Li Kai

AU - Tang, Sung Chun

AU - Chan, Hsin Lung

AU - Yang, Yi Ching

AU - Wu, Yen Wen

AU - Hwang, Juey Jen

AU - Lin, Jiunn Lee

PY - 2020/3

Y1 - 2020/3

N2 - Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.

AB - Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.

UR - http://www.scopus.com/inward/record.url?scp=85065676780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065676780&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2019.04.007

DO - 10.1016/j.jfma.2019.04.007

M3 - Review article

C2 - 31113748

AN - SCOPUS:85065676780

SN - 0929-6646

VL - 119

SP - 674

EP - 684

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

IS - 3

ER -

A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this